Kneel Pharmaceuticals Private Limited
About Kneel Pharmaceuticals Private Limited
Data last updated:
Kneel Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the general construction services segment of the infrastructure and utilities sector. It was incorporated on 25 November 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL2002PTC117781. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Smrita Roy and Satyendra Prasad Sinha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dgl 224 DLF Galleria, Mayur Vihar Phase – 1, Delhi, India – 110091.
As per the financials filed for FY 2024, the company reported a revenue of ₹50,000. For the same year it recorded a net profit of ₹13,527 (net margin 27.1%) and EBITDA of ₹13,527 (EBITDA margin 27.1%). Revenue has declined at a compounded annual rate (CAGR) of 36% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Kneel Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressDgl 224 DLF Galleria, Mayur Vihar Phase – 1, Delhi, India – 110091
- IndustryInfrastructure and Utilities, General Construction Services
To see the full contact details of Kneel Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Kneel Pharmaceuticals Private Limited
FY 2025 filings availableKneel Pharmaceuticals Private Limited reported revenue of ₹50,000 for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 36% over five years. EBITDA rose 321% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13,527 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13,527 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 27.1% | ||||
| Net Profit Margin | 27.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kneel Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kneel Pharmaceuticals Private Limited
Kneel Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Smrita Roy | Director | 03 Feb 2024 | 2 Years 8 Months | Current |
| Satyendra Prasad Sinha Also directs: Grand Eats LLP, Gravy Export Private Limited, Ass Buildwell Private Limited and 2 more | Director | 08 Dec 2014 | 11 Years 10 Months | Current |
Auditor
Kneel Pharmaceuticals Private Limited is audited by DVMEHANDRU& ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DVMEHANDRU& ASSOCIATES | FY 2023 | 005013N |
Shareholding
The shareholding of Kneel Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kneel Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kneel Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kneel Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kneel Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Kneel Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kneel Pharmaceuticals Private Limited has 6 board changes on record since 2014: 2 appointments and 4 cessations. The latest: Smrita Roy ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Kneel Pharmaceuticals is an active private limited company based in Delhi, India. The company works in general construction services, within the infrastructure and utilities industry. It was incorporated on 25 November 2002 (24+ years old) and is registered under CIN U24231DL2002PTC117781.
Kneel Pharmaceuticals has 2 current directors:
- Smrita Roy - Director
- Satyendra Prasad Sinha - Director
The latest financial statements of Kneel Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Kneel Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Kneel Pharmaceuticals is U24231DL2002PTC117781. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kneel Pharmaceuticals was incorporated on 25 November 2002, making it 24+ years old. It is registered with the Registrar of Companies, Delhi.
Smrita Roy ceased to be Additional Director on 29 Sep 2024. Smrita Roy was appointed as Director on 03 Feb 2024. Indu Bala Sinha ceased to be Director on 26 Apr 2021. Kneel Pharmaceuticals has 6 board changes on record in total.
The registered office of Kneel Pharmaceuticals is at Dgl 224 DLF Galleria, Mayur Vihar Phase – 1, Delhi, India – 110091.
Kneel Pharmaceuticals operates in the infrastructure and utilities industry, in the general construction services segment.
The compliance status of Kneel Pharmaceuticals is compliant as of 14 September 2026. The company is actively filing with the Registrar of Companies.